Journal Article

The good and the bad of T cell cross-reactivity: challenges and opportunities for novel therapeutics in autoimmunity and cancer

Gouttefangeas, Cécile, Klein, Reinhild, Maia, Ana

2023

Overview

T cells are main actors of the immune system with an essential role in protection against pathogens and cancer. The molecular key event involved in this absolutely central task is the interaction of membrane-bound specific T cell receptors with peptide-MHC complexes which initiates T cell priming, activation and recall, and thus controls a range of downstream functions. While textbooks teach us that the repertoire of mature T cells is highly diverse, it is clear that this diversity cannot possibly cover all potential foreign peptides that might be encountered during life. TCR cross-reactivity, i.e. the ability of a single TCR to recognise different peptides, offers the best solution to this biological challenge. Reports have shown that indeed, TCR cross-reactivity is surprisingly high. Hence, the T cell dilemma is the following: be as specific as possible to target foreign danger and spare self, while being able to react to a large spectrum of body-threatening situations. This has major consequences for both autoimmune diseases and cancer, and significant implications for the development of T cell-based therapies. In this review, we will present essential experimental evidence of T cell cross-reactivity, implications for two opposite immune conditions, i.e. autoimmunity vs cancer, and how this can be differently exploited for immunotherapy approaches. Finally, we will discuss the tools available for predicting cross-reactivity and how improvements in this field might boost translational approaches.

• Publisher: Frontiers Media SA,Frontiers Media S.A
• Subject: Antigens / Autoimmune diseases / Autoimmune Diseases - therapy / Autoimmunity / Cancer / Cell activation / Cloning / Cross-reactivity / Dengue fever / HIV / Human immunodeficiency virus / Humans / Immune system / Immunity (Disease) / Immunology / Immunotherapy / Influenza / Lymphocytes / Lymphocytes T / Major histocompatibility complex / Neoplasms - therapy / Pathogens / Peptides / Receptors, Antigen, T-Cell / T cell receptor / T cell receptors / T-Lymphocytes / Viruses